Related Experiment Video
Updated: Sep 28, 2025
12:42
Photoactivated Localization Microscopy with Bimolecular Fluorescence Complementation BiFC-PALM
Published on: December 22, 2015
10.1K
A photosensitizing fusion protein with targeting capabilities
Stefano Bruno1, Marilena Margiotta1, Marco Cozzolino2,3
1Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parma, Italy.
Biomolecular Concepts
|March 31, 2022
Summary
Researchers developed a novel photosensitizer by fusing human recombinant myoglobin with vasoactive intestinal peptide. This construct targets prostate cancer cells expressing VPAC receptors, showing potential for targeted photodynamic therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Photodynamic Therapy
Background:
- Photodynamic therapy (PDT) utilizes photosensitizers to generate reactive oxygen species for antimicrobial and anticancer applications.
- PDT effectiveness hinges on photosensitizer specificity for microbial or cancer cells.
- Targeting specific cellular receptors enhances photosensitizer localization and efficacy.
Purpose of the Study:
- To create and characterize a novel photosensitizing construct for targeted cancer therapy.
- To investigate the targeting capability of a human recombinant myoglobin-VPAC receptor construct.
- To evaluate the potential of Zn-protoporphyrin IX as a photosensitizer in this construct.
Main Methods:
- Preparation of human recombinant myoglobin fused to vasoactive intestinal peptide (VIP).
- Incorporation of Zn-protoporphyrin IX as the photosensitizing agent.
- Assessment of construct binding to prostate cancer cells expressing VPAC receptors via fluorescence.
Main Results:
- Successfully synthesized a human recombinant myoglobin-VIP fusion protein.
- Zn-protoporphyrin IX was effectively integrated as the photosensitizer.
- The construct demonstrated specific binding to prostate cancer cells expressing VPAC receptors.
Conclusions:
- The developed myoglobin-VIP-Zn-protoporphyrin IX construct shows promise for targeted photodynamic therapy.
- The construct's ability to bind VPAC-receptor-positive prostate cancer cells is confirmed.
- This approach offers a potential strategy for enhancing the specificity of photodynamic anticancer treatments.
Related Concept Videos
01:24Tagging and Fusion Proteins
7.2K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
7.2K
02:53Conservative Site-specific Recombination and Phase Variation
6.2K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.2K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K